Colon Cancer Microbiome Landscaping: Differences in Right- and Left-Sided Colon Cancer and a Tumor Microbiome-Ileal Microbiome Association.


Journal

International journal of molecular sciences
ISSN: 1422-0067
Titre abrégé: Int J Mol Sci
Pays: Switzerland
ID NLM: 101092791

Informations de publication

Date de publication:
07 Feb 2023
Historique:
received: 30 11 2022
revised: 01 02 2023
accepted: 03 02 2023
entrez: 25 2 2023
pubmed: 26 2 2023
medline: 3 3 2023
Statut: epublish

Résumé

In the current era of precision oncology, it is widely acknowledged that CRC is a heterogeneous disease entity. Tumor location (right- or left-sided colon cancer or rectal cancer) is a crucial factor in determining disease progression as well as prognosis and influences disease management. In the last decade, numerous works have reported that the microbiome is an important element of CRC carcinogenesis, progression and therapy response. Owing to the heterogeneous nature of microbiomes, the findings of these studies were inconsistent. The majority of the studies combined colon cancer (CC) and rectal cancer (RC) samples as CRC for analysis. Furthermore, the small intestine, as the major site for immune surveillance in the gut, is understudied compared to the colon. Thus, the CRC heterogeneity puzzle is far from being solved, and more research is necessary for prospective trials that separately investigate CC and RC. Our prospective study aimed to map the colon cancer landscape using 16S rRNA amplicon sequencing in biopsy samples from the terminal ileum, healthy colon tissue, healthy rectal tissue and tumor tissue as well as in preoperative and postoperative stool samples of 41 patients. While fecal samples provide a good approximation of the average gut microbiome composition, mucosal biopsies allow for detecting subtle variations in local microbial communities. In particular, the small bowel microbiome has remained poorly characterized, mainly because of sampling difficulties. Our analysis revealed the following: (i) right- and left-sided colon cancers harbor distinct and diverse microbiomes, (ii) the tumor microbiome leads to a more consistent cancer-defined microbiome between locations and reveals a tumor microbiome-ileal microbiome association, (iii) the stool only partly reflects the microbiome landscape in patients with CC, and (iv) mechanical bowel preparation and perioperative antibiotics together with surgery result in major changes in the stool microbiome, characterized by a significant increase in the abundance of potentially pathogenic bacteria, such as

Identifiants

pubmed: 36834671
pii: ijms24043265
doi: 10.3390/ijms24043265
pmc: PMC9963782
pii:
doi:

Substances chimiques

RNA, Ribosomal, 16S 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Références

Clin Colorectal Cancer. 2021 Sep;20(3):e165-e172
pubmed: 33935016
Gut Microbes. 2021 Jan-Dec;13(1):1854641
pubmed: 33446008
Gut. 2019 Sep;68(9):1624-1632
pubmed: 31092590
Int J Mol Sci. 2018 Aug 30;19(9):
pubmed: 30200215
Gut. 2022 Jul;71(7):1359-1372
pubmed: 35260444
Cell. 2011 Mar 4;144(5):646-74
pubmed: 21376230
Future Oncol. 2020 Mar;16(7):293-306
pubmed: 32067473
Cancers (Basel). 2021 Sep 25;13(19):
pubmed: 34638284
Gut Microbes. 2021 Jan-Dec;13(1):1-10
pubmed: 34030582
Nat Rev Microbiol. 2016 Jan;14(1):20-32
pubmed: 26499895
J Gerontol A Biol Sci Med Sci. 2017 Oct 12;72(11):1474-1482
pubmed: 28444190
J Clin Med. 2020 Aug 28;9(9):
pubmed: 32872220
Eur J Cancer. 2018 Nov;103:356-387
pubmed: 30100160
PLoS One. 2016 May 12;11(5):e0155362
pubmed: 27171425
Cell Death Differ. 2021 May;28(5):1532-1547
pubmed: 33262469
Nat Methods. 2013 Oct;10(10):996-8
pubmed: 23955772
Gerontology. 2018;64(6):513-520
pubmed: 30025401
Sci Rep. 2018 Mar 16;8(1):4736
pubmed: 29549283
Microorganisms. 2019 Jan 10;7(1):
pubmed: 30634578
Nat Med. 2020 Jun;26(6):919-931
pubmed: 32451498
Microbiome. 2014 Feb 24;2(1):6
pubmed: 24558975
Science. 2015 Dec 4;350(6265):1214-5
pubmed: 26785481
BMC Gastroenterol. 2021 Nov 25;21(1):446
pubmed: 34823504
Bioinformatics. 2010 Oct 1;26(19):2460-1
pubmed: 20709691
Environ Microbiol. 2010 Dec;12(12):3213-27
pubmed: 20626454
Microb Pathog. 2020 Feb 8;142:104052
pubmed: 32045645
Front Oncol. 2020 Nov 25;10:526009
pubmed: 33324541
Semin Cancer Biol. 2022 Nov;86(Pt 2):955-966
pubmed: 34624451
J Natl Compr Canc Netw. 2017 Mar;15(3):411-419
pubmed: 28275039
BMC Microbiol. 2020 Oct 13;20(1):308
pubmed: 33050883
Nat Rev Cancer. 2019 Jul;19(7):371-376
pubmed: 31186547
Clin Transl Med. 2018 Sep 17;7(1):30
pubmed: 30221325
J Pathol. 2018 Apr;244(5):667-676
pubmed: 29377130
J Gastroenterol Hepatol. 2022 Feb;37(2):263-272
pubmed: 34820895
Lancet Oncol. 2012 Jun;13(6):607-15
pubmed: 22575588
Gastroenterology. 2018 Jun;154(8):2152-2164.e19
pubmed: 29458155
Front Immunol. 2020 Dec 14;11:600886
pubmed: 33381121
Gut. 2017 Apr;66(4):633-643
pubmed: 26992426
Gastroenterology. 2020 Jan;158(2):322-340
pubmed: 31586566
Gastroenterology. 2014 Nov;147(5):1055-63.e8
pubmed: 25046162
Lancet. 2014 Apr 26;383(9927):1490-1502
pubmed: 24225001
Lancet Oncol. 2016 Nov;17(11):1480-1482
pubmed: 27819229
Cell. 2000 Jan 7;100(1):57-70
pubmed: 10647931
Science. 2018 Jan 5;359(6371):91-97
pubmed: 29097494
Gut. 2019 Oct;68(10):1820-1826
pubmed: 31097539
BMC Gastroenterol. 2019 Mar 27;19(1):46
pubmed: 30917791
Eur J Cancer. 2017 Oct;84:69-80
pubmed: 28787661
Nat Protoc. 2020 Mar;15(3):799-821
pubmed: 31942082
Gastroenterology Res. 2018 Aug;11(4):264-273
pubmed: 30116425
Sci Rep. 2017 Sep 14;7(1):11590
pubmed: 28912574
Cancer Discov. 2022 Jan;12(1):31-46
pubmed: 35022204
Genome Res. 2012 Feb;22(2):292-8
pubmed: 22009990
CA Cancer J Clin. 2018 Nov;68(6):394-424
pubmed: 30207593
Genome Res. 2009 Dec;19(12):2317-23
pubmed: 19819907
Glob Health Med. 2021 Dec 31;3(6):386-393
pubmed: 35036620
Cancers (Basel). 2020 Oct 16;12(10):
pubmed: 33081401
Anaerobe. 2020 Apr;62:102100
pubmed: 31521732
Oncol Lett. 2019 Jan;17(1):1115-1127
pubmed: 30655873
J Med Microbiol. 2005 Nov;54(Pt 11):1093-1101
pubmed: 16192442
Nucleic Acids Res. 2017 Jul 3;45(W1):W180-W188
pubmed: 28449106
N Engl J Med. 2016 Dec 15;375(24):2369-2379
pubmed: 27974040
Microorganisms. 2021 May 20;9(5):
pubmed: 34065545

Auteurs

Barbara Kneis (B)

Department of Nephrology, University Hospital Erlangen, 91054 Erlangen, Germany.
Department of Surgery, University Hospital Erlangen, 91054 Erlangen, Germany.

Stefan Wirtz (S)

Department of Internal Medicine I, University Hospital Erlangen, 91054 Erlangen, Germany.

Klaus Weber (K)

Department of Surgery, University Hospital Erlangen, 91054 Erlangen, Germany.

Axel Denz (A)

Department of Surgery, University Hospital Erlangen, 91054 Erlangen, Germany.

Matthias Gittler (M)

Department of Surgery, University Hospital Erlangen, 91054 Erlangen, Germany.

Carol Geppert (C)

Institute of Pathology, University Hospital Erlangen, 91054 Erlangen, Germany.

Maximilian Brunner (M)

Department of Surgery, University Hospital Erlangen, 91054 Erlangen, Germany.

Christian Krautz (C)

Department of Surgery, University Hospital Erlangen, 91054 Erlangen, Germany.

Alexander Reinhard Siebenhüner (AR)

Department of Gastroenterology and Hepatology, University Hospital Zurich and University Zurich, 8091 Zürich, Switzerland.

Robert Schierwagen (R)

Department of Internal Medicine B, University Hospital Münster, 48149 Münster, Germany.

Olaf Tyc (O)

Department of Internal Medicine I, University Clinic Frankfurt, 60590 Frankfurt, Germany.

Abbas Agaimy (A)

Institute of Pathology, University Hospital Erlangen, 91054 Erlangen, Germany.

Robert Grützmann (R)

Department of Surgery, University Hospital Erlangen, 91054 Erlangen, Germany.

Jonel Trebicka (J)

Department of Internal Medicine B, University Hospital Münster, 48149 Münster, Germany.

Stephan Kersting (S)

Department of Surgery, University Hospital Greifswald, 17475 Greifswald, Germany.

Melanie Langheinrich (M)

Department of Surgery, University Hospital Greifswald, 17475 Greifswald, Germany.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH